Methyl 2-[1-(3,4-difluorophenyl)propyl-formylamino]acetate | 847448-07-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Methyl 2-[1-(3,4-difluorophenyl)propyl-formylamino]acetate
• CAS: 847448-07-1
• 化学式: C₁₃H₁₅F₂NO₃
• 分子量: 271.264
• InChiKey: MZWQSQDMEBAOIT-UHFFFAOYSA-N

物化性质

• 沸点：
  390.5±42.0 °C(Predicted)
• 密度：
  1?+-.0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  19
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  46.6
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  Methyl 2-[1-(3,4-difluorophenyl)propyl-formylamino]acetate 在 盐酸 、 sodium hydroxide 、 氯化亚砜 、 sodium t-butanolate 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 40.0h， 生成 3-[1-(3,4-difluorophenyl)propyl]-2-sulfanylidene-1H-imidazole-4-carbonyl chloride
  参考文献：
  名称：

  2-Mercaptoimidazoles, a new class of potent CCR2 antagonists

  摘要：

  We describe the synthesis and SAR of a new class of CCR2 antagonists based on a 2-mercaptoimidazole scaffold. The initial lead 1a was optimized to the 3,4-disubstituted analogues 1p-(S) and 1q-(S), which have IC50 values in the MCP-1 induced Ca-flux below 0.01 muM. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.11.064
• 作为产物：
  描述：

  3,4-二氟苯丙酮 在 palladium on activated charcoal 噻吩 、 氢气 作用下， 以 甲醇 、 xylene 为溶剂， 反应 6.0h， 生成 Methyl 2-[1-(3,4-difluorophenyl)propyl-formylamino]acetate
  参考文献：
  名称：

  2-Mercaptoimidazoles, a new class of potent CCR2 antagonists

  摘要：

  We describe the synthesis and SAR of a new class of CCR2 antagonists based on a 2-mercaptoimidazole scaffold. The initial lead 1a was optimized to the 3,4-disubstituted analogues 1p-(S) and 1q-(S), which have IC50 values in the MCP-1 induced Ca-flux below 0.01 muM. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.11.064

文献信息

• Mercaptoimidazoles as Ccr2 Receptor Antagonists
  申请人：Boeckx Maria Gustaaf

  公开号：US20070249691A1

  公开（公告）日：2007-10-25

  The present invention relates to a compound of formula (I) a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine, a polymorphic form or a stereochemically isomeric form thereof, wherein R 1 represents hydrogen, C 1-6 alkyl, C 3-7 cycloalkyl, C 1-6 alkyloxyC 1-6 alkyl, di(C 1-6 alkyl)aminoC 1-6 alkyl, aryl or heteroaryl; each R 2 independently represents halo, C 1-6 alkyl, C 1-6 alkyloxy, C 1-6 alkylthio, polyhaloC 1-6 alkyl, polyhaloC 1-6 alkyloxy, cyano, aminocarbonyl, amino, mono- or di(C 1-4 alkyl)amino, nitro, aryl or aryloxy; R 3 represents hydrogen, cyano, optionally substituted C 1-6 alkyl, C(═O)—O—R 5 , C(═O)—NR 6a R 6b , C(═S)—NR 6a R 6b , S(═O) 2 —NR 6a R 6b or C(═O)—R 7 ; R 4 represents hydrogen or C 1-6 alkyl; n is 1, 2, 3, 4 or 5; Z represents a cyclic ring system. The invention also relates to processes for preparing the compounds of formula (I), their use as CCR2 antagonists and pharmaceutical compositions comprising them.
• 2-Mercaptoimidazoles, a new class of potent CCR2 antagonists
  作者：Guy Van Lommen、Julien Doyon、Erwin Coesemans、Staf Boeckx、Marina Cools、Mieke Buntinx、Bart Hermans、Jean VanWauwe

  DOI：10.1016/j.bmcl.2004.11.064

  日期：2005.2

  We describe the synthesis and SAR of a new class of CCR2 antagonists based on a 2-mercaptoimidazole scaffold. The initial lead 1a was optimized to the 3,4-disubstituted analogues 1p-(S) and 1q-(S), which have IC50 values in the MCP-1 induced Ca-flux below 0.01 muM. (C) 2004 Elsevier Ltd. All rights reserved.